Search

everythinglearnresearchcommunity

for

Search:↓

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.

Better supportive care is needed to manage chemotherapy side effects.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Intravenous calcium therapy is a safe and effective treatment for a rare type of rickets.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Later line chemotherapy causes severe side effects, impacting quality of life, but patients continue treatment to extend life and stay connected with loved ones.

Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.

Cutaneous vesicostomy and cystoscopic valve ablation both have pros and cons for managing posterior urethral valves.

Vorasidenib can cause unusual hair growth.

Personalized treatment and teamwork among doctors can reduce chemotherapy side effects and improve patient outcomes.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Isolated hyperthermic chemotherapy perfusion for limb melanoma is safe and effective with manageable side effects.

Some chemotherapy can cause permanent hair loss.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

AS101 reduces hair loss from chemotherapy.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.